Simultaneous analysis of cannabinoid and synthetic cannabinoids in dietary supplements using UPLC with UV and UPLC-MS-MS

Journal of Analytical Toxicology

Volumn 40, Issue 5, 2016, Pages 350-359

  Heo, Seok ^a   Yoo, Geum Joo ^a   Choi, Ji Yeon ^a   Park, Hyoung Joon ^a   Do, Jung Ah ^a   Cho, Sooyeul ^a   Baek, Sun Young ^a   Park, Sung Kwan ^a  

^a National Institute of Food and Drug Safety Evaluation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1 BUTYL 3 (1 NAPHTHOYL)INDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID; JWH 081; JWH 122; JWH 250; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; XLR 11; STREET DRUG;

ACCURACY; ARTICLE; DIETARY SUPPLEMENT; FOOD; FOOD ANALYSIS; LIQUID; MICROCAPSULE; POWDER; SENSITIVITY AND SPECIFICITY; TABLET; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; VALIDATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PROCEDURES; SUBSTANCE ABUSE;

CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84973149504     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkw027     Document Type: Article

References (25)

1. Strano-Rossi, S., Anzillotti, L., Castrignano, E., Romolo, F.S., Chiarotti, M. (2012) Ultrahigh performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, 'spice' and stimulants in oral fluid. Journal of Chromatography, 1258, 37-42.
2. Merola, G., Aturki, Z., D'Orazid, G., Gottaedo, R., Macchia, T., Tagliaro, F. et al. (2012) Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 71, 45-53.
3. Lemos, N.P., Ingle, E.A. (2011) Cannabinoids in postmortem toxicology. Journal of Analytical Toxicology, 35, 394-401.
4. Hall, W., Solowij, N. (1998) Adverse effects of cannabis. The Lancet, 352, 1611-1616.
5. Ashton, A.C. (1999) Adverse effects of cannabis and cannabinoids. British Journal of Anesthesia, 83, 637-649.
6. Grotenhermen, F. (2007) The toxicology of cannabis and cannabis prohibition. Chemistry and Biodiversity, 4, 1744-1769.
7. Khiabani, H.Z., Mørland, J., Bramness, J.G. (2008) Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis. European Journal of Internal Medicine, 19, 608-612.
8. Zimmermann, U.S., Winkelmann, P.R., Pilhatsch, M., Nees, J.A., Spanagel, R., Schulz, K. (2009) Withdrawal phenomena and dependence syndrome after the consumption of 'spice gold'. Deutsches Arzteblatt International, 106, 464-467.
9. Every-Palmer, S. (2010) Warning: legal synthetic cannabinoid- receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105, 1859-1860.
10. Muller, H., Sperling, W., Kohrmann, M., Huttner, H.B., Kornhuber, J., Maler, J.M. (2010) The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309-310.
11. Simmons, J., Cookman, L., Kang, C., Skinner, C. (2011) Three cases of 'spice' exposure. Clinical Toxicology, 49, 431-433.
12. Benford, D.M., Caplan, J.P. (2011) Psychiatric sequelae of spice, K2 and synthetic cannabinoid receptor agonists. Psychosomatics, 52, 295.
13. Kosior, D.A., Filipiak, K.J., Stolarz, P., Opolski, G. (2001) Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association. International Journal of Cardiology, 78, 183-184.
14. Korantzopoulos, P., Liu, T., Papaioannides, D., Li, G., Gou-de venos, J.A. (2008) Atrial fibrillation and marijuana smoking. International Journal of Clinical Practice, 62, 308-313.
15. Bachs, L., Mørland, H. (2001) Acute cardiovascular fatalities following cannabis use. Forensic Science International, 124, 200-203.
16. Stoppacher, R. (2012) Synthetic cannabinoid use and sudden death. AFP Journal, 2, 202-206.
17. Shanks, K.G.,Winston, D., Heidingsfelder, J., Behonick, G. (2015) Case reports of synthetic cannabinoid XLR-11 associated fatalities. Forensic Science International, 252, e6-e9.
18. Vardakou, I., Pistos, C., Spiliopoulou, C.H. (2010) Spice drugs as a new trend: mood of action, identification and legislation. Toxicology Letters, 197, 157-162.
19. Mustata, C., Torrens, M., Pardo, R., Perez, C., Farre, M. (2009) Spice drugs: cannabinoids as new designer drugs. Addicciones, 21, 181-186.
20. Sobolevsky, T., Prasolov, I., Rodchenkov, G. (2010) Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200, 141-147.
21. Teske, J., Weller, J.P., Feiguth, A., Rothamel, T., Schulz, Y., Troger, H.D. (2010) Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalene-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 878, 2659-2663.
22. Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., Auwarter, V. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163-171.
23. Schaefer, N., Peters, B., Bregel, D., Maurer, H.H., Schmidt, P.T., Ewald, A. H. (2014) Can JWH-210 and JWH-122 be detected in adipose tissue four weeks after single oral drug administration to rats? Biomedical Chromatography, 28, 1043-1047.
24. International Conference on Harmonisation (ICH). (2005) Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1).
25. de Beer, J.O., de Beer, T.R., Goeyens, L. (2007) Assessment of quality performance parameters for straight line calibration curves related to the spread of the abscissa values around their mean. Analytica Chimica Acta, 584, 57-65.